Europe PDX models market is projected to register a substantial CAGR of 16.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027
Market Segmentation:
Europe PDX Models Market, By Type (Mice Models and Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Lung Tumor Models, Urological Tumor Models, Hematological Tumor Models and Others), Application (Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research and Biomarker Analysis), Technique (Heterotopic Implantation and Orthotropic Implantation), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Organizations and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe) Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of the Europe PDX models market are:

• Rising demand for humanized PDX models
• Growth in CROs and academic research institutions for cancer research

Market Players:

The key market players for Europe PDX models market are listed below:

• Crown Bioscience
• Champions Oncology, Inc.
• Charles River Laboratories
• Wuxi AppTec
• Onco Design
• Covance Inc.
• EPO Berlin-Buch Gmbh
• EUROPDX.
• Explora Biolabs
• Horizon Discovery Ltd.
• Urosphere SAS
• Xentech
• Xenopat